Exabis Library
Welcome to the e-CCO Library!
P218: Over 30% of active flares in inflammatory bowel disease patients are associated with gastrointestinal infectious agents
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P218: The cost-effectiveness of biological therapy cycles in the management of Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P218: Venous thromboembolism in a Finnish IBD cohort
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P219 Disease-specific avoidance is a predictor for fatigue in inflammatory bowel disease patients
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P219: Accuracy of imaging for the preoperative measurement of the ileocolonic Crohn’s disease length: results of a prospective cohort study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P219: An application of artificial intelligence in Inflammatory Bowel Disease detection
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P219: Impact of COVID-19 pandemic in patients with a first consultation for suspected inflammatory bowel disease.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P219: Inflammatory bowel disease in children is a challenging diagnosis when overlaps with coeliac disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P219: Migraine Is Associated with the Development of Inflammatory Bowel Disease: A Nationwide, Population-Based Study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P219: Mucosal healing and histological remission in paediatric ulcerative colitis: Does the target change the outcomes?
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P219: Retrospective investigation of tacrolimus combined with an anti-TNFα antibody as remission induction therapy for refractory ulcerative colitis: efficacy, safety, and relapse rate
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P220 Predictors of prognosis after discontinuation of first-use biologics in IBD patients with at least 24 months follow-up
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P220: CROHN'S DISEASE (CD): The predictive value of Montreal clinical patterns, and biological treatment in a Latin American IBD reference center.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P220: Current practices in Ileal pouch surveillance for ulcerative colitis patients in Three London IBD referral centres
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P220: IBIS-Q (IBd Identification of Spondyloarthrytis Questionnaire): a new tool to detect spondyloarthritis in inflammatory bowel diseases
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P220: Patient's disease perception and health-related quality of life with IBD: Results from a Spanish cohort with 15 years of follow up
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P220: Patient-entered symptoms scores collected using a new IBD patient portal correlate closely with clinical assessment and can optimise delivery of IBD care
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P220: Safety of stricturoplasty for Crohn’s disease in the era of biologics
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P220: Total colonoscopy is needed to establish the diagnosis of lymphocytic colitis: results from a single-centre retrospective cohort
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P221 Thromboembolic events in hospitalised patients with inflammatory bowel disease – a large tertiary hospital experience
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM